Navigation Links
Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies
Date:4/3/2012

ALEXANDRIA, Va., April 3, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced a $15 million round of debt financing for NanoString Technologies, Inc. ("NanoString").  The financing package, which was awarded to NanoString from both Oxford and Silicon Valley Bank, included a $13 million senior secured term loan and a $2 million revolving line of credit.  Proceeds of the term loan will fund the company's growth, and the revolver will be used for working capital.

"NanoString has a novel and cost-saving technology that will greatly benefit a variety of discovery and translational research applications," said Christopher A. Herr, managing director for Oxford Finance. "Oxford is very pleased to provide capital to support NanoString's ongoing growth and product distribution, as well as the expected launch of its first in vitro diagnostic product, a breast cancer assay based on the PAM50 gene expression signature."

"While NanoString continues its pursuit of new trials and regulatory approvals, this financing is intended to give the company the additional financial runway it needs to meet its milestones," said Brian Boatman, senior relationship manager for Silicon Valley Bank. "We are committed to bringing our experience with successful life sciences companies to the table and are pleased to help NanoString grow the diagnostics side of its business."

"This facility further strengthens NanoString's balance sheet, allowing us to continue growing our core life sciences business while aggressively pursuing the diagnostics opportunity," said Wayne Burns, NanoString's Chief Financial Officer. "Oxford and SVB have been efficient and constructive capital partners, and we look forward to working together."

About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.

About Silicon Valley Bank
Silicon Valley Bank is the premier bank for technology, life sciences, cleantech, venture capital, private equity and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment and international banking services to its clients worldwide through 26 U.S. offices and seven international operations. (Nasdaq: SIVB) www.svb.com.

Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System.  SVB Financial Group is also a member of the Federal Reserve System.

About NanoString Technologies
NanoString Technologies is a privately held provider of life sciences tools for translational research and developer of molecular diagnostics. The company's nCounter® Analysis System is the first and only technology platform to deliver highly multiplexed, direct profiling of individual molecules in a single reaction without amplification. The nCounter Analysis System offers a cost-effective way to easily profile hundreds of gene transcripts, copy number variations, or miRNAs simultaneously with high sensitivity and precision.  The company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. NanoString is also developing the technology for use in molecular diagnostics.

 


'/>"/>
SOURCE Oxford Finance LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
2. Bavarian Nordics Case Against Oxford BioMedica
3. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
4. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
5. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
6. Oxford BioTherapeutics Appoints Michael Moore as Chairman
7. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
8. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
9. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
10. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
11. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):